NCT05210816View on ClinicalTrials.gov

Acceptance and Commitment Therapy (ACT) in Early Psychosis Patients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

September 30, 2022

Conditions
Acceptance and Commitment TherapyPsychotic DisordersPsychiatric Nursing
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy

Acceptance and Commitment Therapy Based Intervention Program was applied to the intervention group in eight sessions online. Each session will last an average of 60-90 minutes. There will be two sessions for one group per week.

Trial Locations (1)

34668

Saglik Bilimleri Universitesi, Istanbul

All Listed Sponsors
lead

Saglik Bilimleri Universitesi

OTHER

NCT05210816 - Acceptance and Commitment Therapy (ACT) in Early Psychosis Patients | Biotech Hunter | Biotech Hunter